[go: up one dir, main page]

ES8300096A1 - "un procedimiento para preparar derivados de halofenil-piridil-alilamina". - Google Patents

"un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Info

Publication number
ES8300096A1
ES8300096A1 ES508064A ES508064A ES8300096A1 ES 8300096 A1 ES8300096 A1 ES 8300096A1 ES 508064 A ES508064 A ES 508064A ES 508064 A ES508064 A ES 508064A ES 8300096 A1 ES8300096 A1 ES 8300096A1
Authority
ES
Spain
Prior art keywords
preparing
procedure
derivatives
halofenyl
alylamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES508064A
Other languages
English (en)
Other versions
ES508064A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of ES8300096A1 publication Critical patent/ES8300096A1/es
Publication of ES508064A0 publication Critical patent/ES508064A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/48Aldehydo radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR DERIVADOS DEL HALOFENIL-PIRIDIL-ALILAMINA. CONSISTE EN CONVERTIR UNA CETONA DE FORMULA GENERAL (I) CON UN ILURO DE FOSFORO PREPARADO EN SITU O PRESINTETIZADO. SE OBTIENE EL COMPUESTO (II) QUE OPCIONALMENTE SE TRANSFORMA EN LA SAL CORRESPONDIENTE FARMACEUTICAMENTE ACEPTABLE Y/O SE CONVIERTE EN EL ISOMERO E O Z DEL MISMO. R ES H O CH ELEVADO 3; N ES 1 O 2 Y X ES UN HALOGENO TAL COMO F, CL, BR O I; CUANDO ES BR, ESTE ESTARA UNIDO EN UNA POSICION DISTINTA DE 1 A 4. EL GRUPO PIRIDILO Y LA FUNCION AMINO ESTAN EN CONFIGURACION CIS. *FORMULA*.
ES508064A 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina". Granted ES508064A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7909514A SE7909514L (sv) 1979-11-16 1979-11-16 Nya halofenyl-pyridyl-allylaminderivat

Publications (2)

Publication Number Publication Date
ES8300096A1 true ES8300096A1 (es) 1982-10-01
ES508064A0 ES508064A0 (es) 1982-10-01

Family

ID=20339337

Family Applications (5)

Application Number Title Priority Date Filing Date
ES496859A Granted ES496859A0 (es) 1979-11-16 1980-11-14 Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES508063A Expired ES8300095A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508065A Granted ES508065A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508064A Granted ES508064A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508062A Granted ES508062A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES496859A Granted ES496859A0 (es) 1979-11-16 1980-11-14 Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES508063A Expired ES8300095A1 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES508065A Granted ES508065A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES508062A Granted ES508062A0 (es) 1979-11-16 1981-12-16 "un procedimiento para preparar derivados de halofenil-piridil-alilamina".

Country Status (17)

Country Link
US (1) US4418065A (es)
EP (2) EP0029420A1 (es)
JP (1) JPS56501524A (es)
AU (1) AU538087B2 (es)
CA (1) CA1155128A (es)
DK (1) DK300781A (es)
ES (5) ES496859A0 (es)
FI (1) FI812196L (es)
GR (1) GR72129B (es)
NO (1) NO812401L (es)
NZ (1) NZ195558A (es)
PL (3) PL129369B1 (es)
PT (1) PT72066B (es)
SE (1) SE7909514L (es)
SU (4) SU1103794A3 (es)
WO (1) WO1981001407A1 (es)
ZA (1) ZA807102B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1150269A (en) * 1980-11-14 1983-07-19 Carl B. J. Ulff Process for preparing 3-(4-bromophenyl)-3-(3-pyridyl)-allylamines
US4610995A (en) * 1984-07-27 1986-09-09 Coker Geoffrey G Certain 1,1-diaryl-propenyl-3-(1-pyrrolidino-2-carboxylic acids, derivatives thereof and their anti-histaminic properties
GB8814639D0 (en) * 1988-06-20 1988-07-27 Ici Plc Heterocyclic tertiary alcohol derivatives
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6800652B2 (en) 2002-08-16 2004-10-05 Pfizer Inc. Diaryl compounds
GB0219154D0 (en) * 2002-08-16 2002-09-25 Pfizer Ltd Diaryl compounds
US9822075B2 (en) * 2013-11-05 2017-11-21 Astrazeneca Ab NMDA antagonist prodrugs

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676964A (en) * 1950-06-07 1954-04-27 Schering Corp 3-pyridyl propylamine antihistamine substances
DE966534C (de) * 1951-03-22 1957-08-22 Schering Corp Verfahren zur Herstellung von basisch substituierten Pyridinverbindungen
GB850298A (en) 1956-10-30 1960-10-05 Maggioni & C Societa Per Azion ª‡,ª‡[(p-chlorophenyl)-(4-pyridyl)] carbinols and method of preparing same
DE1468359A1 (de) * 1963-10-23 1968-11-28 Merck & Co Inc Verfahren zur Herstellung von Dibenzocycloheptehderivaten
US3396224A (en) * 1965-09-09 1968-08-06 Lilly Co Eli Controlling phytopathogenic fungi on plants with 3-pyridyl methane derivatives
US3423510A (en) * 1966-08-31 1969-01-21 Geigy Chem Corp 3-(p-halophenyl) - 3 - (2'-pyridyl-n-methylpropylamine for the treatment of depression
US3471505A (en) * 1967-02-01 1969-10-07 Ciba Geigy Corp 1-(alkoxyphenyl)-1-(3-pyridyl)-carbinols
SE361663B (es) 1971-04-28 1973-11-12 Haessle Ab
US3928613A (en) * 1971-04-28 1975-12-23 Haessle Ab Compounds useful as antidepressive agents
US3928369A (en) * 1971-04-28 1975-12-23 Haessle Ab Compounds useful as antidepressive agents, and a process for their preparation
SE373850B (es) * 1972-11-16 1975-02-17 Haessle Ab
US4094908A (en) * 1973-08-15 1978-06-13 Richter Gedeon Vegyeszeti Gyar Rt. Alpha-substituted benzhydrol derivatives
GB1480593A (en) * 1973-11-30 1977-07-20 Kefalas As Xanthene and thioxanthene derivatives having pharmaceutical activity
US4186202A (en) * 1974-11-21 1980-01-29 Astra Lakemedel Aktiebolag Phenyl-pyridylamine derivatives
US4102887A (en) * 1974-11-21 1978-07-25 Per Arvid Emil Carlsson Intermediates used in the preparation of phenyl-pyridylamine derivatives
SE388854B (sv) 1974-11-21 1979-03-26 Astra Laekemedel Ab Forfarande for framstellning av fenylpyridylaminderivat
SE418291B (sv) * 1976-05-17 1981-05-18 Astra Laekemedel Ab 4-bromfenyl-3-pyridylderivat som mellanprodukter vid framstellning av fenylpyridylaminer
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
SE418399B (sv) * 1976-05-21 1981-05-25 Astra Laekemedel Ab Forfarande for framstellning av n,n-dimetyl-3-(4 bromfenyl)-3-(3-pyridyl)allylamin
SE409860B (sv) * 1977-07-04 1979-09-10 Astra Laekemedel Ab En ny mellanprodukt for framstellning av terapeutiskt aktiva pyridinforeningar
IE47628B1 (en) * 1977-07-04 1984-05-16 Astra Laekemedel Ab Substituted aralkyl amines and amino-aryl alkenes having therapeutic activity
SE409861B (sv) * 1977-07-04 1979-09-10 Astra Laekemedel Ab Ett nytt forfarande for framstellning av en terapeutisk aktiv pyridinforening

Also Published As

Publication number Publication date
NO812401L (no) 1981-07-13
ES8204721A1 (es) 1982-05-01
PL232732A1 (es) 1982-08-16
PL232731A1 (es) 1982-08-16
SU1149874A3 (en) 1985-04-07
SU1138021A3 (ru) 1985-01-30
PT72066B (en) 1982-09-02
CA1155128A (en) 1983-10-11
ES508063A0 (es) 1982-10-01
ES8300095A1 (es) 1982-10-01
SU1149875A3 (ru) 1985-04-07
DK300781A (da) 1981-07-07
AU538087B2 (en) 1984-07-26
ES8300097A1 (es) 1982-10-01
PL227849A1 (es) 1981-12-23
PL129370B1 (en) 1984-05-31
JPS56501524A (es) 1981-10-22
FI812196A7 (fi) 1981-07-10
EP0029420A1 (en) 1981-05-27
ES508065A0 (es) 1982-10-01
ES8300094A1 (es) 1982-10-01
PT72066A (en) 1980-12-01
SE7909514L (sv) 1981-05-17
SU1103794A3 (ru) 1984-07-15
EP0081478A2 (en) 1983-06-15
EP0081478A3 (en) 1984-01-04
PL129369B1 (en) 1984-05-31
PL128457B1 (en) 1984-01-31
AU6437880A (en) 1981-05-21
ES508064A0 (es) 1982-10-01
WO1981001407A1 (en) 1981-05-28
ZA807102B (en) 1981-07-29
ES508062A0 (es) 1982-10-01
FI812196L (fi) 1981-07-10
GR72129B (es) 1983-09-16
NZ195558A (en) 1984-07-06
US4418065A (en) 1983-11-29
ES496859A0 (es) 1982-05-01

Similar Documents

Publication Publication Date Title
DK0547165T3 (da) Fremgangsmåde til fremstilling af vandopløselige camptothecinanaloger såvel som forbindelserne 10-hydroxy-11-C(1-6)-alkoxyc
DE68912044D1 (de) Verfahren zur Herstellung einer Bitumen-Polymer-Zusammensetzung.
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DE3064749D1 (en) New pyrazoline derivatives, method of preparing the new compounds, as well as insecticidal composition on the basis of these new compounds
DK469379A (da) Fremgangsmaade til fremstilling af 1-hydroxylerede 5,6-vitamind-forbindelser
DE69003906D1 (de) Triacetin enthaltende, langwirkende injizierbare Zusammensetzungen.
ES8300096A1 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
DD137225A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
JPS5263183A (en) Stabilizer for organic materials
JPS51142046A (en) Stabilized polymer composition
DK158472C (da) Saccharosederivater, fremgangsmaade til fremstilling deraf og disses anvendelse som soedemidler
DK146534C (da) Fremgangsmaade til fremstilling af rene substituerede n-methyl-pyrazol-acetanilider
IT1038688B (it) 1.2.4 triazolil i derivati processo per la loro preparazione loro impiego come sdiancanti ottici
JPS537748A (en) Synthetic resin composition having improved light resistance and gas-stain resistance
ES485933A0 (es) Procedimiento para preparar compuesto 2-imino-1, 3-ditio-he-terociclicos sustituidos.
DK154085C (da) Fremgangsmaade til fremstilling af 1,1-dioxopenicillansyrederivater
DK549979A (da) Fremgangsmaade til fremstilling af 7-chlor-2-methyl-3,3a-dihydro-2h,9h-isoxazolo-(3,2-b)-1,3-benzoxazin-9-on
AT373257B (de) Verfarhren zur herstellung neuer 2,3,5,8-tetrahydrofuro- bzw. 5,8-dihydrofuro-1,8-naphthyridine-verbindung
ES2053257T3 (es) Derivados de pradimicina.
JPS5536484A (en) Novel 1*44dihydropyridazinee33carboxylic acid derivative
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ES2090344T3 (es) Procedimiento para la preparacion de derivados de beta-carbolina.
DK129380A (da) Fremgangsmaade til fremstilling af 6,7-dialkoxy-1-piperidinophthalazin-forbindelser eller syreadditionssalte deraf
ES449991A1 (es) Procedimiento para la preparacion de derivados de acido 7 (alfaamino-omega-(2,3-metilenodioxifenil y acilamido) cefa- losporanico.
ES8500057A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina.